Carmat SA (EPA:ALCAR)

Market Cap	46.72M
Revenue (ttm)	6.93M
Net Income (ttm)	-53.35M
Shares Out	57.53M
EPS (ttm)	-1.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	123,225
Average Volume	117,000
Open	0.8300
Previous Close	0.8350
Day's Range	0.7900 - 0.8400
52-Week Range	0.6930 - 4.4000
Beta	1.43
RSI	34.91
Earnings Date	Apr 30, 2025

About Carmat

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 182
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALCAR

Financial Performance

In 2023, Carmat's revenue was 3.84 million, an increase of 704.40% compared to the previous year's 477,000. Losses were -53.87 million, 0.35% more than in 2022.